Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06864260 · ClinicalTrials.gov registry record · NA
Cancer PRevention Through Enhanced EnvironMenT
A NA study of Cancer Risk, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06864260: Active NA study of Cancer Risk, sponsored by University of Alabama at Birmingham.
NCT06864260 is a NA study of Cancer Risk that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 300 participants, below the 13,986-participant average among 7 other Cancer Risk trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06864260, a NA study of Cancer Risk, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of Cancer PRevention through Enhanced EnvironMenT (Cancer PREEMpT) is to test whether a comprehensive intervention that improves the neighborhood built and social environment can reduce community-level cancer risk in persistent poverty (PP) areas. Our overall hypothesis is that enhancements of the living environment (both built and social) will lower cancer risk through several mechanisms. Built environment improvements will impact walkability (through improved lighting, sidewalks, green space) and access to preventive care (through a mobile wellness van and community health workers), which will stimulate health-related behaviors (physical activity, cancer screening). These improvements will also positively impact safety (through blight removal, traffic calming), social cohesion (through opportunities for socialization), and collective efficacy (through improved neighborhood perceptions). Social environment improvements will increase social cohesion (through community-led events) and collective efficacy (through a Community Leadership Academy and community grants), which will improve public safety as well as facilitate health-related behaviors (physical activity, prevention/wellness). Both types of improvements (built and social environment) will help reduce chronic stress, which will lower the PP community's cancer risk.
Primary Outcome
10 indicators that make up allostatic load (AL) score, a measure of the cumulative burden of stress. The AL score is defined as sum score of the number of biomarkers that are above the set threshold, with a high level being 3 or more biomarkers above the threshold.
Conditions Studied
Interventions
- OTHER Built Environment
- OTHER Social Environment
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
What the registry record for NCT06864260 still lists
NCT06864260 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 13,986-participant average among 7 other Cancer Risk trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cancer Risk appearing as the primary indexed condition, and to 2 interventions - of which Built Environment is the first listed.
NCT06864260 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06864260 about?
NCT06864260 is a clinical study titled "Cancer PRevention Through Enhanced EnvironMenT". The goal of Cancer PRevention through Enhanced EnvironMenT (Cancer PREEMpT) is to test whether a comprehensive intervention that improves the neighborhood built and social environment can reduce community-level cancer risk in persistent poverty (PP) areas. Our overall hypothesis is that enhancements...
What is the current status of trial NCT06864260?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-05-01. Estimated completion is 2028-04-30.
What conditions does trial NCT06864260 study?
This clinical trial studies the following conditions: Cancer Risk.
What interventions are being tested in trial NCT06864260?
The interventions under investigation include: Built Environment (OTHER), Social Environment (OTHER).
Who is sponsoring clinical trial NCT06864260?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06864260 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
RECRUITING · NA
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
-
Norris ORIEN Total Cancer Care
RECRUITING
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Morehouse Total Cancer Care Protocol
RECRUITING
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI